NCT02217865 Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer Status COMPLETED Phase N/A
NCT02215642 Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China Status UNKNOWN Phase N/A
NCT02210260 Pain Relief After Colorectal Surgery: Spinal Combined With Painbuster® vs Painbuster® Alone. Status COMPLETED Phase NA
NCT02204332 Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment Status TERMINATED Phase PHASE2
NCT02202928 Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT02202096 A Pilot Randomized Trial of a Comprehensive Transitional Care Program for Colorectal Cancer Patients Status WITHDRAWN Phase NA
NCT02198092 Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes Status COMPLETED Phase N/A
NCT02196688 Study of Fruquintinib in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02191969 Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer Status COMPLETED Phase NA
NCT02191761 Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02188927 Effect of an Advanced Notification Letter on Screening Colonoscopy Participation Status UNKNOWN Phase NA
NCT02186236 Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients Status COMPLETED Phase N/A
NCT02185443 Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases Status RECRUITING Phase PHASE2
NCT02181465 Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma. Status COMPLETED Phase PHASE2
NCT02175095 [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib Status COMPLETED Phase NA
NCT02169388 Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy Status UNKNOWN Phase PHASE1
NCT02164916 S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02162563 Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases Status COMPLETED Phase PHASE3